We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Is There Already a Need of Reckoning on Cancer Immunotherapy?
- Authors
Correale, Pierpaolo; Pentimalli, Francesca; Baglio, Giovanni; Krstic-Demonacos, Marjia; Saladino, Rita Emilena; Giordano, Antonio; Mutti, Luciano
- Abstract
Conflicts of Interest continue to plague oncology guidelines and research - cancer therapy advisor. Keywords: immunotherapy; cancer; study design; real world evidences; mesothelioma EN immunotherapy cancer study design real world evidences mesothelioma N.PAG N.PAG 1 05/03/21 20210326 NES 210326 The last decades of translational research on cancer immunobiology are allowing the design of profoundly innovative treatments for cancer. Lancet Oncology ([43]) itself published an authoritative editorial raising a serious warning on the threat posed by the "hype" and information spread across on cancer immunotherapy, and more in general on many new cancer therapies.
- Subjects
IMMUNOTHERAPY; IPILIMUMAB; IMMUNE checkpoint inhibitors; NON-small-cell lung carcinoma; MEDICAL specialties &; specialists; MEDICAL societies; HOSPITAL central service departments
- Publication
Frontiers in Pharmacology, 2021, Vol 11, pN.PAG
- ISSN
1663-9812
- Publication type
Article
- DOI
10.3389/fphar.2021.638279